NCT06291532

Brief Summary

Intellectual disability (ID) and autism spectrum disorder (ASD) are often co-occurring neurodevelopmental disorders that require composite intervention. However, standardized rehabilitation programs presented several limitations due to behavioral problems and poor engagement in proposed activity. The Virtual Reality Rehabilitation System (VRRS) is a medical device is recognized as one of the most advanced systems to rehabilitate patients with motor, cognitive, linguistic and behavioral disorders. The use of VRRS offers the opportunity to adapting task parameters according to the patient's performance and the virtual system increases engagement and avoids boredom and frustration. the patients underwent a two months experimental intervention integrated into the regular activity of a semi-residential center for autistic adolescents and young adults.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

February 9, 2024

Completed
24 days until next milestone

First Posted

Study publicly available on registry

March 4, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

March 4, 2024

Status Verified

February 1, 2024

Enrollment Period

2.5 years

First QC Date

February 9, 2024

Last Update Submit

February 26, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Usability questionnaire

    The questionnaire used a 5-point ordinal scale, where 5 is the most favorable score and 1 is the least favorable score; the score 3 corresponds to "no opinion". The questionnaire will be completed by all therapists at the end of the treatment.

    T0 (BASELINE) - T1 (SIX MONTHS)

  • Virtual Reality Rehabilitation System (VRRS) electromedical device parameters: screen attention time

    During the execution of the exercise, the attention time maintained on the screen was recorded.

    T0 (BASELINE) -T1 (SIX MONTHS)

  • Virtual Reality Rehabilitation System (VRRS) electromedical device parameters: the number of repetitions of the exercises.

    During the execution of the exercise, the number of repetitions of the exercises was recorded

    T0 (BASELINE) -T1 (SIX MONTHS)

  • Virtual Reality Rehabilitation System (VRRS) electromedical device parameters:global scores for exercise.

    The total scores obtained were recorded during the execution of the exercise.

    T0 (BASELINE) -T1 (SIX MONTHS)

Study Arms (1)

Experimental Group (EG)

EXPERIMENTAL

The group consists of patients diagnosed with autism spectrum disorder and intellectual disability who underwent treatment with VRRS

Device: Rehabilitation with VRRS

Interventions

The patients underwent an experimental intervention lasting two months (9 sessions lasting about 40 minutes) integrated into the regular activity of a semi-residential center for autistic adolescents and young adults. The proposed exercises were 2D and the patient interacted with the scenarios through the touch screen. For all participants, the tasks were the same, but difficulty and duration varied according to the needs and goals to be achieved.

Experimental Group (EG)

Eligibility Criteria

Age6 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • subjects diagnosed with ASD and ID, according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5);
  • age between 6 and 40 years;
  • cognitive level \<65 Intellectual Quotient
  • signed informed consent

You may not qualify if:

  • subjects without diagnosis of ASD and ID, according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5);
  • age not between 6 and 40 years;
  • cognitive level \>65 Intellectual Quotient
  • unsigned informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Centro Neurolesi Bonino Pulejo

Messina, 98124, Italy

Location

Related Publications (2)

  • Bernard Paulais MA, Mazetto C, Thiebaut E, Nassif MC, Costa Coelho De Souza MT, Stefani AP, Blanc R, Gattegno MP, Aiad F, Sam N, Belal L, Fekih L, Kaye K, Contejean Y, Wendland J, Barthelemy C, Bonnet-Brilhault F, Adrien JL. Heterogeneities in Cognitive and Socio-Emotional Development in Children With Autism Spectrum Disorder and Severe Intellectual Disability as a Comorbidity. Front Psychiatry. 2019 Jul 19;10:508. doi: 10.3389/fpsyt.2019.00508. eCollection 2019.

    PMID: 31396112BACKGROUND
  • De Luca R, Bonanno M, Rifici C, Pollicino P, Caminiti A, Morone G, Calabro RS. Does Non-Immersive Virtual Reality Improve Attention Processes in Severe Traumatic Brain Injury? Encouraging Data from a Pilot Study. Brain Sci. 2022 Sep 8;12(9):1211. doi: 10.3390/brainsci12091211.

    PMID: 36138947BACKGROUND

MeSH Terms

Conditions

Autism Spectrum DisorderIntellectual Disability

Interventions

Rehabilitation

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 9, 2024

First Posted

March 4, 2024

Study Start

April 1, 2023

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

March 4, 2024

Record last verified: 2024-02

Locations